Home » FDA Approves Novo Nordisk Hemophilia A Drug
FDA Approves Novo Nordisk Hemophilia A Drug
The FDA has granted Novo Nordisk a clear path for its biologics license for the hemophilia A drug Novoeight.
Pharma Times
Pharma Times
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May